Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Cognitive Dysfunction × Modafinil × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Fatigue 21 Neoplasms 6 cyclopia sequence 4 Glioma 3 Central Nervous System Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Brain Neoplasms 3 Sleepiness 2 Sleep Initiation and Maintenance Disorders 2 Pain 2 Lung Neoplasms 2 Head and Neck Neoplasms 2 Breast Neoplasms 2 Unspecified Adult Solid Tumor, Protocol Specific 1 Sleep Wake Disorders 1 Prostatic Neoplasms 1 Parasomnias 1 Oligodendroglioma 1 Neurotoxicity Syndromes 1 Nervous System Neoplasms 1 Multiple Myeloma 1 Meningioma 1 Melanoma 1 Lymphoma, B-Cell 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Laryngeal Diseases 1 Gliosarcoma 1 Glioma, Subependymal 1 Glioblastoma 1 Esophageal Neoplasms 1

Interventions

Exercise 6 Transcranial Direct Current Stimulation 4 Walking 3 Memantine 3 Tablets 2 Standard of Care 2 Methods 2 Donepezil 2 Cognitive Behavioral Therapy 2 mazdutide 1 lithium sulfate 1 lime 1 fasudil 1 enzalutamide 1 blueberry extract 1 beta Carotene 1 acetaminophen, aspirin, caffeine drug combination 1 XENP 1595 1 Waiting Lists 1 Vitamin E 1 Vitamin D 1 Ultraviolet Therapy 1 Transcranial Magnetic Stimulation 1 Time 1 Therapeutics 1 Tai Ji 1 Sugars 1 Sodium Chloride 1 Sirolimus 1 Silymarin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05333250 2026-01-13

MODIFY

Ottawa Hospital Research Institute

Phase 1/2 Recruiting

Fatigue, Neoplasms, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon ⚡